Nuvation Bio Inc. (NUVB)

NYSE

$4.57

$-0.02

(-0.41%)

Pre-Market

Nuvation Bio Inc. (NUVB) Live Price Chart

Last updated: ⁦2026-10-29 11:28:00⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Nuvation Bio Inc. (NUVB) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NYSE. The stock is currently priced at $4.57, with a market capitalization of $1.60B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $3.92 to $9.75. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$1.60B
Open	$4.59
Day's High	$15.23
Day's Low	$0.95
Previous Close	$4.59
Volume	3.00
Average Volume	5.33M
P/E Ratio	--
52-Week High	$9.75
52-Week Low	$3.92
Dividend Yield	--
Earnings Date	--

Nuvation Bio Inc. (NUVB) Pre-Market Stock Price

Nuvation Bio Inc. (NUVB) is trading at $4.57 in pre-market trading as of 2026-10-29 11:01:00, down 0.52% ($0.02) from the previous close of $4.59

Pre-market trading shows how investors are pricing NUVB before the regular session opens. The current pre-market price is below the previous close, indicating cautious early trading sentiment.

Nuvation Bio Inc. (NUVB) 7-Day Stock Price Change

Over the past seven days, Nuvation Bio Inc. (NUVB) moved from $4.77 to $4.57, representing a decline of 4.28% ($0.20).

The stock traded between $4.36 and $4.96 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.

The average daily volume was 4.90 million shares, up versus the previous seven-day period, indicating higher trading activity.

NUVB 52-Week Price Position

Position in Range: 11.1%

52W Low$3.92

52W High$9.75

NUVB is currently trading at $4.57, placing it 11.1% of the way from its 52-week low of $3.92 to its 52-week high of $9.75. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Nuvation Bio Inc. (NUVB)?

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in different stages of development. The Company generates revenue from out-licensing collaborative agreements, including product revenue, upfront license fees, royalty revenue, and research and development services revenue. The Company generates the majority of its revenue from Japan.

Nuvation Bio Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	305
Exchange	NYSE
Company Website	https://www.nuvationbio.com

How to Buy Nuvation Bio Inc. (NUVB) Stock on MEXC

Eligible investors can buy real shares of Nuvation Bio Inc. (NUVB) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for NUVB and Place Your Order

Open the RealStocks trading page and search for NUVB. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Nuvation Bio Inc. (NUVB) stock price today?

Nuvation Bio Inc. (NUVB) is currently trading at $ 4.57, down 0.52% ($0.02) from the previous close of $ 4.59. Intraday prices update in real time during regular trading hours.

2.Is NUVB stock going up or down today?

As of 2026-10-29 11:01:00, NUVB is trading at $ 4.57, down 0.52% ($0.02) from its previous close of $ 4.59. The stock has traded between $ 0.95 and $ 15.23 during today’s regular session. Past price movements do not guarantee future results.

3.What is NUVB pre-market price?

As of 2026-10-29 11:01:00, NUVB is trading at $ 4.57 in pre-market trading, down 0.52% ($0.02) from the previous close of $ 4.59. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is NUVB after-hours price?

As of 2026-10-29 11:01:00, NUVB is trading at $ 4.59 in after-hours trading, down 0.11% ($0.00) from the regular-session close of $ 4.59. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is NUVB stock trading now?

NUVB trades on the NYSE exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does NUVB sit relative to its 52-week high and low?

Over the past 52 weeks, NUVB has traded between a low of $ 3.92 and a high of $ 9.75. At $ 4.57, the stock is positioned 11.1% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Nuvation Bio Inc. in?

Nuvation Bio Inc. (NUVB) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Nuvation Bio Inc.'s market capitalization and where is it listed?

Nuvation Bio Inc. is listed on the NYSE exchange with a market capitalization of $ 1.60B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is NUVB valued in terms of P/E ratio and EPS?

NUVB trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -0.43. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Nuvation Bio Inc. pay a dividend?

Nuvation Bio Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.